Potential Cancer Drug Target and Biomarker for KBTBD13 (G390594)

Target Name: KBTBD13

NCBI ID: G390594

KBTBD13

Potential Cancer Drug Target and Biomarker for KBTBD13

KBTBD13, also known as KBTBD-HUMAN, is a protein that is expressed in human tissues and has been identified as a potential drug target in the treatment of various diseases, including cancer. The protein is involved in the regulation of cell growth, apoptosis (programmed cell death), and angiogenesis (the formation of new blood vessels).

Research has shown that KBTBD13 plays a crucial role in the development and progression of many diseases, including cancer. For example, studies have shown that KBTBD13 is highly expressed in various types of cancer, including breast, lung, and colorectal cancer. Additionally, the protein has been shown to promote the growth and survival of cancer cells, and to inhibit the production of anti-cancer drugs.

Due to its involvement in the regulation of cell growth and apoptosis, KBTBD13 has been identified as a potential drug target for cancer treatment. Researchers are currently working to develop small molecules and other compounds that can inhibit the activity of KBTBD13 and prevent its promotion of cancer cell growth. These compounds are being tested in a variety of preclinical and clinical studies to determine their effectiveness in treating cancer.

In addition to its potential as a cancer drug target, KBTBD13 has also been shown to have potential as a biomarker for the diagnosis and monitoring of cancer. The protein is expressed in a variety of tissues and has been shown to be downregulated in cancer cells compared to normal cells. Additionally, studies have shown that KBTBD13 can be used as a marker for the assessment of disease status in cancer patients, with lower levels of KBTBD13 indicating a more aggressive form of cancer.

Overall, KBTBD13 is a protein that has great potential as a drug target for cancer treatment and as a biomarker for the diagnosis and monitoring of cancer. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: Kelch Repeat And BTB Domain Containing 13

Functions: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex

The "KBTBD13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KBTBD13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets